Close Menu

Pacific Biosciences' sequencer has made it from idea to tangible product, with its recent shipments of its PacBio RS instrument — though this BusinessWeek article points out that sequencing has been, and will continue to be, a challenging field for a company to make its mark on. However, PacBio is hopeful about its sequencing technology. "The ability to observe these things in real time has been the goal of modern biology for the last 50 years," says CSO Eric Schadt.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.